SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-22-002703
Filing Date
2022-04-15
Accepted
2022-04-15 10:17:34
Documents
57
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K charmarx_i10k-123121.htm   iXBRL 10-K 1149826
2 CERTIFICATION cannapharm_ex3101.htm EX-31.1 11209
3 CERTIFICATION cannapharm_ex3102.htm EX-31.2 11086
4 CERTIFICATION cannapharm_ex32.htm EX-32 4677
  Complete submission text file 0001683168-22-002703.txt   4562508

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cpmd-20211231.xsd EX-101.SCH 38691
6 XBRL CALCULATION FILE cpmd-20211231_cal.xml EX-101.CAL 52562
7 XBRL DEFINITION FILE cpmd-20211231_def.xml EX-101.DEF 147395
8 XBRL LABEL FILE cpmd-20211231_lab.xml EX-101.LAB 281752
9 XBRL PRESENTATION FILE cpmd-20211231_pre.xml EX-101.PRE 233722
51 EXTRACTED XBRL INSTANCE DOCUMENT charmarx_i10k-123121_htm.xml XML 503375
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27055 | Film No.: 22829234
SIC: 2834 Pharmaceutical Preparations